Liver Failure is NOT Typically Present in Systemic Sclerosis
The answer is e) liver failure. Liver failure is not a recognized manifestation of systemic sclerosis, while all other options listed are well-established features of the disease.
Why Each Option Relates to Systemic Sclerosis
Features That ARE Present in SSc:
a) Raynaud's Phenomenon
- Nearly all patients with SSc have Raynaud's phenomenon 11
- Often one of the earliest manifestations, occurring in combination with puffy fingers and positive ANA as "red flag features" of very early SSc 2
- Treated with calcium channel blockers (especially nifedipine) as first-line therapy 11
b) Elevated ANA Titer
- Positive antinuclear antibodies are a characteristic autoimmune feature of SSc 33
- Part of the diagnostic triad (Raynaud's phenomenon, puffy fingers, positive ANA) that alerts clinicians to very early SSc 2
- Specific autoantibodies (anti-Scl-70, anti-centromere, anti-RNAPIII) help define disease subsets and predict organ involvement 1
c) "Renal Crisis" (Scleroderma Renal Crisis)
- Scleroderma renal crisis is a recognized and serious complication of SSc 331
- Particularly associated with anti-RNAPIII antibodies, early diffuse cutaneous SSc, and glucocorticoid use 11
- Requires regular blood pressure monitoring in high-risk patients 1
- Historically a common cause of death, though incidence and mortality have decreased with ACE inhibitor use 4
d) Pulmonary Fibrosis (Interstitial Lung Disease)
- ILD is common in SSc, found in 40-75% of patients based on lung function changes 11
- Progressive in 15-18% of patients 1
- Now the most common cause of death in SSc, having surpassed renal crisis 4
- Mycophenolate mofetil is first-line treatment, with nintedanib for progressive fibrotic disease 11
The Feature That is NOT Present:
e) Liver Failure
- Liver failure is not listed among the organ manifestations in any of the major SSc guidelines 3311
- The 2025 EULAR recommendations cover 8 clinical/organ domains: Raynaud's phenomenon, digital ulcers, pulmonary arterial hypertension, scleroderma renal crisis, skin fibrosis, ILD, gastrointestinal manifestations, and arthritis—notably excluding liver failure 33
Important Caveat
While liver failure is not a typical SSc manifestation, primary biliary cholangitis (PBC) can occur in 8% of limited cutaneous SSc cases, usually in patients with anti-centromere antibodies 11. However, PBC is a distinct autoimmune liver disease that can overlap with SSc—it is not "liver failure" as a direct manifestation of systemic sclerosis itself. Patients may have elevated alkaline phosphatase and generalized pruritus, but this represents an overlap syndrome rather than SSc-related liver involvement.